Although our data do not demonstrate a direct correlation between the density of CD163+ macrophages and survival, their presence in almost all GBM tumor samples is a further confirmation of the importance of macrophages as a possible target of immunotherapy in high-grade gliomas [98,99]. This evidence concerns the gene CD163 and glioma.